We are live on
!
Find out more
Primecap Management Portfolio holdings
AUM
$127B
1-Year Est. Return
44.11%
This Fund
S&P 500
This Quarter
Est. Return
+5.02%
1 Year Est. Return
+44.11%
3 Year Est. Return
+121.64%
5 Year Est. Return
+154.22%
10 Year Est. Return
+724.54%
AUM
$91.3B
AUM Growth
+$2.98B
(+3.4%)
Cap. Flow
-$825M
Cap. Flow
% of AUM
-0.9%
Top 10 Holdings %
Top 10 Hldgs %
34.96%
Holding
259
New
7
Increased
73
Reduced
140
Closed
5
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
United Airlines
UAL
|
+$144M |
| 2 |
Jacobs Solutions
J
|
+$83.6M |
| 3 |
CSX Corp
CSX
|
+$52.1M |
| 4 |
Ross Stores
ROST
|
+$51.1M |
| 5 |
Thermo Fisher Scientific
TMO
|
+$47.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GSK
GSK
|
+$218M |
| 2 |
Electronic Arts
EA
|
+$134M |
| 3 |
FedEx
FDX
|
+$124M |
| 4 |
Medtronic
MDT
|
+$120M |
| 5 |
Visa
V
|
+$83.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.32% |
| 2 | Healthcare | 25.97% |
| 3 | Industrials | 13.87% |
| 4 | Financials | 5.85% |
| 5 | Consumer Discretionary | 5.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Biogen
BIIB
$29.6B
| $5.44B | 5.96% |
17,258,311
-243,795
| -1% | -$73.4M |
|
2
Amgen
AMGN
$201B
| $3.77B | 4.13% |
31,853,844
-307,900
| -1% | -$35.6M |
|
3
Eli Lilly
LLY
$1.06T
| $3.55B | 3.89% |
57,102,840
-26,868
| -0% | -$1.6M |
|
4
Alphabet (Google) Class C
GOOG
$3.88T
| $2.99B | 3.27% |
103,286,196
-400,034
| -0.4% | -$10.9M |
|
5
Adobe
ADBE
$84.3B
| $2.8B | 3.06% |
38,666,674
-482,580
| -1% | -$31.1M |
|
6
Texas Instruments
TXN
$259B
| $2.74B | 3% |
57,420,166
-460,376
| -0.8% | -$21.5M |
|
|
7
FedEx
FDX
$74.7B
| $2.72B | 2.98% |
17,974,996
-889,300
| -5% | -$124M |
|
8
Microsoft
MSFT
$2.83T
| $2.66B | 2.92% |
63,897,236
-294,495
| -0.5% | -$11.9M |
|
9
Novartis
NVS
$297B
| $2.16B | 2.36% |
26,612,399
-187,879
| -0.7% | -$14.8M |
|
10
Southwest Airlines
LUV
$21.9B
| $2.11B | 2.31% |
78,488,794
-727,627
| -0.9% | -$18.3M |
|
|
11
Medtronic
MDT
$105B
| $1.89B | 2.07% |
29,602,228
-1,967,960
| -6% | -$120M |
|
|
SCHW
12
Charles Schwab
SCHW
$177B
| $1.7B | 1.86% |
63,057,255
-1,782,318
| -3% | -$46.8M |
|
|
MON
13
DELISTED
Monsanto Co
MON
| $1.58B | 1.73% |
12,699,872
-568,140
| -4% | -$66.5M |
|
14
Qualcomm
QCOM
$180B
| $1.49B | 1.63% |
18,826,768
-208,530
| -1% | -$16.6M |
|
15
Transocean
RIG
$5.89B
| $1.42B | 1.55% |
31,454,626
+912,060
| +3% | +$38.8M |
|
16
Johnson & Johnson
JNJ
$624B
| $1.28B | 1.4% |
12,242,420
-58,566
| -0.5% | -$5.92M |
|
17
HP
HPQ
$22.4B
| $1.24B | 1.36% |
81,360,388
+1,972,133
| +2% | +$29.6M |
|
18
Bath & Body Works
BBWI
$3.9B
| $1.21B | 1.33% |
25,611,789
+778,684
| +3% | +$35.6M |
|
|
DTV
19
DELISTED
DIRECTV COM STK (DE)
DTV
| $1.19B | 1.3% |
14,006,090
-117,000
| -0.8% | -$9.53M |
|
20
Micron Technology
MU
$1.12T
| $1.15B | 1.26% |
34,863,335
-308,500
| -0.9% | -$8.41M |
|
|
MRSH
21
Marsh
MRSH
$84.2B
| $1.12B | 1.23% |
21,672,151
-1,489,700
| -6% | -$74M |
|
22
Intel
INTC
$504B
| $1B | 1.1% |
32,462,551
+1,132,500
| +4% | +$31M |
|
|
EMC
23
DELISTED
EMC CORPORATION
EMC
| $934M | 1.02% |
35,476,239
+528,150
| +2% | +$13.9M |
|
|
SNDK
24
DELISTED
SANDISK CORP
SNDK
| $908M | 0.99% |
8,698,415
-123,370
| -1% | -$11.2M |
|
25
Intuit
INTU
$77B
| $890M | 0.97% |
11,052,383
-137,700
| -1% | -$10.6M |
|
Similar funds
Primecap Management's Q2 2014 Portfolio in Review
As of Q2 2014, Primecap Management held 259 positions worth $91.3B, up 3.4% from $88.4B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Trading was light in Q2 2014: portfolio turnover was 4.6%. Primecap Management opened 7 new positions and exited 5, leaving the 259-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 28% a quarter earlier, followed by Healthcare and Industrials.
- Primecap Management's largest Q2 2014 buy was Exact Sciences: 2,491,300 shares worth $42.4M.
- Primecap Management added most to United Airlines in Q2 2014, an estimated $144M increase.
- Primecap Management's biggest Q2 2014 reduction was GSK, cutting an estimated $218M.
- Primecap Management fully exited Akamai in Q2 2014, selling an estimated $4.77M.
- Primecap Management's ten largest holdings make up 35% of its $91.3B portfolio in Q2 2014.
- Primecap Management opened 7 new positions and closed 5 in Q2 2014.
- Primecap Management's portfolio value rose 3.4% quarter-over-quarter to $91.3B.
Based on Primecap Management's 13F filing for Q2 2014, filed 14 Aug 2014.